HC disapproves of ED's "unreasonable" move to freeze entire bank accountsQuestioning the agency’s move, the High Court quipped “the foreign government has nothing to lose. It is your own citizen who is losing. Th...
Sudhir Vaila looks to raise up to Rs 500 croreDeutsche Bank along with another foreign lender may extend the three-year credit expected to come from the lender’s overseas branch, two pe...
Making Ranbaxy units cGMP compliant time consuming: Sun PharmaThe company expects to complete the remediation steps in at least one of these facilities in this fiscal, Sun Pharma Managing Director Dili...
Jet Airways replaces acting CEO Gaurang Shetty, fifth change in last two and half yearsA senior executive said it was implemented as Shetty is a member of the board and "it is company policy that an executive in the position o...
Progressive Punjab faces its I-test todayCaptains of top industrial houses will converge in Mohali on Wednesday to commit investments in Punjab.
Suzlon's former finance chief Amit Agarwal may be the next Jet Airways CFOAmit Agarwal will likely join Jet Airways in the last week of September, subject to his appointment being approved by the ministry of civil...
Mukesh Ambani regains richest Indian slot from Dilip ShanghviAccording to a 'real-time' update, Shanghvi slipped to the second position with a networth of $ 19.3 billion among the richest Indian billi...
Sun Pharma ends over 8% down as Daiichi exits; a good buy?Sun Pharmaceuticals ended the day 8.86 per cent down at Rs 951.60. It had plunged 11% in intraday trade after Daiichi Sankyo exited the com...
Daiichi Sankyo sells Sun Pharma stake in block deals; stock plungesSun Pharma were under selling pressure and plunged as much as 10.63% in intraday trade as Daiichi Sankyo offloaded its entire stake.
Need $60 billion a year to power growth: Suresh PrabhuSuresh Prabhu while citing the example of Hyundai, which exported cars from India to market them globally, said that India's change has bee...
Going by market value, Sun Pharma's Dilip Shanghvi is richest IndianIf one adds the 23% stake in wind energy major Suzlon, that Shanghvi and his family is in the process of acquiring, his wealth would be nea...
Sun Pharmaceuticals founder Dilip Shanghvi in talks to acquire stake in Suzlon EnergyDilip Shanghvi's brother-in-law Sudhir Valia will provide Rs 4,000 crore, which the debt-hit Suzlon will use to meet its working capital ne...
Sun Pharma-Ranbaxy combine creates a new market leader in Indian marketThe proposed new entity would unseat Abbott from the top position, which holds current market share of 6.5%, according to research firm Aio...
Sun Pharma's promoters to be Telenor's new Indian JV partnerAfter months of searching, Telenor has finally found a new partner for its telecom operations in India - Sun Pharma's promoters.
- Sun Pharma plans to delist Caraco, offers share buyback
Sun Pharma said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it.
- Indian film industry woos international audiences at Cannes
The dry run of Indian films at Cannes notwithstanding, Bollywood is trying its best to woo the global audiences by screening films at festi...
- Sun warns Taro against the sale of its Irish biz
On the heels of Taro Pharmaceutical filing law suits against Sun Pharma, the Mumbai-based drug firm has threatened to hit back and warned t...